Elisa Y. Lai, Lutz Ackermann and Magnus J. Johansson
{"title":"芳烃的元选择性甲基化、单、二和三氟甲基化的统一方法","authors":"Elisa Y. Lai, Lutz Ackermann and Magnus J. Johansson","doi":"10.1039/D5SC01367D","DOIUrl":null,"url":null,"abstract":"<p >Matched molecular series (MMS) are series of molecules that differ only by a single modification at a specific site. The synthesis of MMS is a desirable strategy in drug discovery campaigns. Small aliphatic motifs, notably methyl, mono-, di- and trifluoromethyl substituents (C<small><sub>1</sub></small> units), are known to have profound effects on the physiochemical properties and/or potency of drug candidates. In this context, we herein report a unique strategy for achieving direct <em>meta</em>-selective methylation, mono-, di-, and trifluoromethylation from the same parent compound. This approach takes advantage of a highly <em>meta</em>-selective ruthenium(<small>II</small>)-catalyzed alkylation, followed by a subsequent photocatalyzed protodecarboxylation or silver-mediated fluorodecarboxylation to reveal the (fluoro)methyl moiety. This method enables the late-stage access to MMS in small molecules bearing a variety of orienting groups as well as bio-relevant molecules containing complex functionalities, bypassing the need for <em>de novo</em> synthesis to access individual compounds in a series. Moreover, key physiochemical properties of drug candidates were successfully modulated, highlighting opportunities to accelerate medicinal chemistry programs in a sustainable fashion.</p>","PeriodicalId":9909,"journal":{"name":"Chemical Science","volume":" 19","pages":" 8478-8486"},"PeriodicalIF":7.4000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2025/sc/d5sc01367d?page=search","citationCount":"0","resultStr":"{\"title\":\"A unified approach to meta-selective methylation, mono-, di- and trifluoromethylation of arenes†\",\"authors\":\"Elisa Y. Lai, Lutz Ackermann and Magnus J. Johansson\",\"doi\":\"10.1039/D5SC01367D\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Matched molecular series (MMS) are series of molecules that differ only by a single modification at a specific site. The synthesis of MMS is a desirable strategy in drug discovery campaigns. Small aliphatic motifs, notably methyl, mono-, di- and trifluoromethyl substituents (C<small><sub>1</sub></small> units), are known to have profound effects on the physiochemical properties and/or potency of drug candidates. In this context, we herein report a unique strategy for achieving direct <em>meta</em>-selective methylation, mono-, di-, and trifluoromethylation from the same parent compound. This approach takes advantage of a highly <em>meta</em>-selective ruthenium(<small>II</small>)-catalyzed alkylation, followed by a subsequent photocatalyzed protodecarboxylation or silver-mediated fluorodecarboxylation to reveal the (fluoro)methyl moiety. This method enables the late-stage access to MMS in small molecules bearing a variety of orienting groups as well as bio-relevant molecules containing complex functionalities, bypassing the need for <em>de novo</em> synthesis to access individual compounds in a series. Moreover, key physiochemical properties of drug candidates were successfully modulated, highlighting opportunities to accelerate medicinal chemistry programs in a sustainable fashion.</p>\",\"PeriodicalId\":9909,\"journal\":{\"name\":\"Chemical Science\",\"volume\":\" 19\",\"pages\":\" 8478-8486\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.rsc.org/en/content/articlepdf/2025/sc/d5sc01367d?page=search\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemical Science\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/sc/d5sc01367d\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Science","FirstCategoryId":"92","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/sc/d5sc01367d","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
A unified approach to meta-selective methylation, mono-, di- and trifluoromethylation of arenes†
Matched molecular series (MMS) are series of molecules that differ only by a single modification at a specific site. The synthesis of MMS is a desirable strategy in drug discovery campaigns. Small aliphatic motifs, notably methyl, mono-, di- and trifluoromethyl substituents (C1 units), are known to have profound effects on the physiochemical properties and/or potency of drug candidates. In this context, we herein report a unique strategy for achieving direct meta-selective methylation, mono-, di-, and trifluoromethylation from the same parent compound. This approach takes advantage of a highly meta-selective ruthenium(II)-catalyzed alkylation, followed by a subsequent photocatalyzed protodecarboxylation or silver-mediated fluorodecarboxylation to reveal the (fluoro)methyl moiety. This method enables the late-stage access to MMS in small molecules bearing a variety of orienting groups as well as bio-relevant molecules containing complex functionalities, bypassing the need for de novo synthesis to access individual compounds in a series. Moreover, key physiochemical properties of drug candidates were successfully modulated, highlighting opportunities to accelerate medicinal chemistry programs in a sustainable fashion.
期刊介绍:
Chemical Science is a journal that encompasses various disciplines within the chemical sciences. Its scope includes publishing ground-breaking research with significant implications for its respective field, as well as appealing to a wider audience in related areas. To be considered for publication, articles must showcase innovative and original advances in their field of study and be presented in a manner that is understandable to scientists from diverse backgrounds. However, the journal generally does not publish highly specialized research.